Elisa Landin-Basterra

Elisa Landin-Basterra

Auto-generated profile, based on publicly available information

Elisa Landin-Basterra

ISGlobal, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2025 in eClinicalMedicine
Verified
Journal Article
Open access
EBElisa Landin Basterra
Elisa Landin Basterra
UGUgo Gentilini
Ugo Gentilini
DCDaniella Medeiros Cavalcanti
Daniella Medeiros Cavalcanti
ASAndrea Ferreira da Silva
Andrea Ferreira da Silva
LSLucas de Oliveira Ferreira de Sales
Lucas de Oliveira Ferreira de Sales
Davide RasellaDavide Rasella
Davide Rasella
Under-5 mortality and malnutrition are major public health challenges in low- and middle-income countries (LMICs), worsened by crises like the COVID-19 pandemic. Evidence on social protection reducing under-5 mortality in LMICs is limited. We examined the impact of social protection coverage, defined as the proportion of the population covered by any form of social protection, on under-5 mortality, stunting, and wasting across 46 LMICs from 2000 to 2021. Our study analyzed 1012 country-year observations. Outcomes included under-5 mortality (deaths per 1000 live births), prevalence of wasting (weight-for-height Z-scores < −2 SD), and stunting (height-for-age Z-scores < −2 SD). Coverage of social protection was defined as the proportion of the population receiving at least one social protection benefit. We used fixed-effects Poisson models with robust standard errors to estimate associations, adjusting for socioeconomic, healthcare, and gender-related variables. Interaction terms captured social protection mitigation effects during COVID-19, and counterfactual scenarios estimated averted deaths. Analyses were disaggregated by sex and age groups. Social protection coverage prevented an estimated 3.05 million under-5 deaths overall, including 583,590 during the pandemic. Higher coverage was significantly associated with reductions in under-5 mortality (IRR:0.71,95%CI:0.54–0.96), stunting (IRR:0.75,95%CI:0.60–0.94), and wasting (IRR:0.87,95%CI:0.78–0.98). During the COVID-19 pandemic years, social protection led to additional reductions in under-5 mortality (IRR:0.68,95%CI:0.59–0.79) and stunting (IRR:0.74,95%CI:0.57–0.95). Toddler mortality (1–2 years) showed the greatest reduction effects (IRR:0.62,95%CI:0.41–0.95). Females showed slightly stronger effects. Sensitivity and triangulation analyses validated all results. Social protection coverage strongly reduced child mortality, stunting, and wasting in LMICs, with heightened impact during the pandemic years. Scaling up social protection programs can be crucial for reducing health inequities, building child resilience, and advancing child health targets in the future. This study was funded by the Rapid Social Response (RSR) Multidonor Trust Fund at the 10.13039/100004421 World Bank .

21 August 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
JOJosé Alejandro Ordoñez
José Alejandro Ordoñez
DCDaniella Cavalcanti
Daniella Cavalcanti
MFMelisane Regina Lima Ferreira
Melisane Regina Lima Ferreira
AZAlejandro Zamudio
Alejandro Zamudio
ASAndréa Ferreira Silva
Andréa Ferreira Silva
Davide RasellaDavide Rasella
Davide Rasella
Background: Social protection programs may influence chronic disease outcomes by shaping living conditions and access to healthcare, yet evidence on their effects on adult non-communicable diseases (NCDs) in low- and middle-income countries (LMICs) remains limited. We examined the effects of social assistance on reported diagnoses of diabetes and hypertension among low-income adults in Brazil and Mexico. Methods: A two-country quasi-experimental study using nationally representative health survey data collected between 2018 and 2019. The study included 21,616 individuals living in low-income households, representing a weighted population of 35,607,974 adults in Brazil and Mexico. Inverse probability of treatment weighting (IPTW)–weighted logistic regression models were used to estimate the effects of social assistance on reported diagnosis of diabetes and hypertension, adjusting for sociodemographic and health-related confounders. Sensitivity analyses produced consistent results. Findings: Receipt of social assistance was associated with lower odds of reporting a diagnosis of diabetes (OR=0·80; 95% CI: 0·73–0·87) and hypertension (OR=0·81; 95% CI: 0·76–0·85). Associations were stronger among individuals in the lowest income strata (OR for diabetes=0·74; 95% CI: 0·66–0·84) and more pronounced in Mexico across overall and stratified analyses by sex and income. Interpretation : Among low-income adults in Brazil and Mexico, receipt of social assistance was associated with lower odds of reported diagnosis of diabetes and hypertension, consistent with a potential effect on chronic disease prevalence. These findings suggest that social assistance may influence NCDs outcomes through pathways related to socioeconomic conditions and healthcare access.

13 August 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
JOJosé Alejandro Ordoñez
José Alejandro Ordoñez
DCDaniella Cavalcanti
Daniella Cavalcanti
MFMelisane Regina Lima Ferreira
Melisane Regina Lima Ferreira
AZAlejandro Zamudio
Alejandro Zamudio
ASAndrey Ferreira da Silva
Andrey Ferreira da Silva
Davide RasellaDavide Rasella
Davide Rasella
Background: Social protection programs may influence chronic disease outcomes by shaping living conditions and access to healthcare, yet evidence on their effects on adult non-communicable diseases (NCDs) in low- and middle-income countries (LMICs) remains limited. We examined the effects of social assistance on reported diagnoses of diabetes and hypertension among low-income adults in Brazil and Mexico.Methods: A two-country quasi-experimental study using nationally representative health survey data collected between 2018 and 2019. The study included 21,616 individuals living in low-income households, representing a weighted population of 35,607,974 adults in Brazil and Mexico. Inverse probability of treatment weighting (IPTW)–weighted logistic regression models were used to estimate the effects of social assistance on reported diagnosis of diabetes and hypertension, adjusting for sociodemographic and health-related confounders. Sensitivity analyses produced consistent results.Findings: Receipt of social assistance was associated with lower odds of reporting a diagnosis of diabetes (OR=0·80; 95% CI: 0·73–0·87) and hypertension (OR=0·81; 95% CI: 0·76–0·85). Associations were stronger among individuals in the lowest income strata (OR for diabetes=0·74; 95% CI: 0·66–0·84) and more pronounced in Mexico across overall and stratified analyses by sex and income.Interpretation: Among low-income adults in Brazil and Mexico, receipt of social assistance was associated with lower odds of reported diagnosis of diabetes and hypertension, consistent with a potential effect on chronic disease prevalence. These findings suggest that social assistance may influence NCDs outcomes through pathways related to socioeconomic conditions and healthcare access.

18 September 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
CSCourtney Sciarratta
Courtney Sciarratta
GJGabriela dos Santos de Jesus
Gabriela dos Santos de Jesus
PKPeter Kirwan
Peter Kirwan
HSHugo Santa
Hugo Santa
ASAndréa Ferreira da Silva
Andréa Ferreira da Silva
Davide RasellaDavide Rasella
Davide Rasella
Background. Concerns have been raised about the potential negative consequences of recent large scale reductions in Official Development Assistance (ODA) funding to lower-and-middle-income-countries (LMICs). This study aimed to comprehensively evaluate the impact of ODA funding on under-five (U5) mortality and undernutrition over the past two decades, and to assess the potential health effects of alternative mitigation strategies in response to current ODA defunding trends, including donors meeting the target of 0.7% of gross national income (GNI) for ODA and the short-term reallocation of debt-related payments. Methods. We conducted an integrated retrospective evaluation and forecasting analysis using longitudinal individual-level data from 62 LMICs during 2002–2035, comprising 11.2 million child-years. First, we estimated the associations between ODA per capita and U5 mortality, wasting, stunting, and other healthcare outcomes using two-way fixed-effects multivariable Poisson regression models with robust standard errors, adjusted for all relevant demographic, socioeconomic, and health-system covariates. We then assessed heterogeneity according to sex, area of residence, and wealth level, and conducted sensitivity and triangulation analyses to evaluate the robustness and causal interpretation of the findings. Finally, we integrated the retrospective estimates into calibrated dynamic microsimulation models to project U5 mortality and undernutrition outcomes through 2035 under different ODA funding scenarios. Findings. Higher ODA funding levels were associated with 26% lower U5 mortality (incidence rate ratio (IRR) 0.74; 95% confidence interval (CI) 0.70-0.78), 47% lower prevalence of severe U5 stunting (prevalence ratio (PR) 0.53; 95% CI 0.50-0.57), and 65% lower prevalence of severe U5 wasting (PR 0.35; 95% CI 0.29-0.41). They were also associated with a 55% higher prevalence of births delivered in a medical facility (PR 1·55; 95% CI 1·53–1·58), a 49% higher prevalence of antenatal care (ANC) initiation in the first trimester (PR 1·49; 95% CI 1·44–1·54), and a 34% higher prevalence of eight or more ANC visits (PR 1·34; 95% CI 1·21–1·49). Associations were stronger in rural areas and lower-income groups. Over 2027-2035 in the selected 62 LMICs, an estimated 2.11 million (95% uncertainty interval (UI): 0.61–3.55 million) U5 deaths were averted in the debt-interest reallocation scenario, 3.84 million (1.83–5.72 million) in the debt service scenario, and 4.55 million (2.46–6.57 million) in the donor GNI 0.7% scenario. Corresponding estimates of averted stunting and wasting case-years were 46.3 million (36.0-57.0 million) and 27.4 million (19.0-36.4 million) for debt-interest reallocation, respectively; 92.9 million (78.0-109.0 million) and 53.2 million (39.3-67.6 million) for debt-service reallocation; and 106.1 million (93.0-119.3 million) and 54.0 million (43.8-65.1 million) for the donor GNI 0.7% scenario. Interpretation. Higher ODA funding has played a decisive role in reducing avoidable child mortality and undernutrition across LMICs over the past two decades. The abrupt withdrawal of this support threatens to undermine this progress and impose a substantial health burden on children worldwide. Conversely, mitigation policies involving increased donor funding and the short-term reallocation of debt-related payments could avert millions of child deaths and cases of undernutrition over the next decade.

29 September 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
ASAndréa Silva
Andréa Silva
PGPriscila Scaff Gestal
Priscila Scaff Gestal
DCDaniella Cavalcanti
Daniella Cavalcanti
ELElisa Landin-Basterra
Elisa Landin-Basterra
GJGabriela dos Santos de Jesus
Gabriela dos Santos de Jesus
Davide RasellaDavide Rasella
Davide Rasella
Objective. To evaluate the extent to which the world's largest and most well established Conditional Cash Transfer (CCT) program, the Bolsa Família Program (BFP), reduced health inequities in the incidence of AIDS, tuberculosis (TB), and child mortality in Brazil. Design. Health impact evaluation within a large-scale cohort study. Setting. Brazil, from January 1 2004 to December 31 2015. Participants. We use three cohorts totaling 92,382,204 million individuals: i) Cohort 1: 22,788,997 individuals aged 13 and older from 2007 to 2015 for the analysis of AIDS incidence; ii) Cohort 2: 54,759,252 individuals from 2004 to 2015 for the analysis of TB incidence; iii) Cohort 3: 14,833,955 children under the age of 5 from 2004 to 2015 for the analysis of child mortality. Interventions. We began by assessing the excess incidence and mortality attributable to poverty severity. To estimate the reduction in health inequities associated with the BFP, we applied multiple inequality indices. We then conducted impact evaluations of BFP’s effects across wealth deciles, employing Inverse Probability Treatment Weighting (IPTW) multivariable Poisson regressions adjusted for all relevant socioeconomic, demographic, and health variables at the individual, household, and municipal levels. Main outcome measures. Incidence of AIDS, incidence of TB, and child mortality Results. Receiving BFP benefits eliminated the excess incidence and mortality associated with extreme poverty, significantly reducing the Gini, Theil, and Concentration Index values. Among the extremely poor, BFP was associated with reductions in the incidence of AIDS by 49%(RR: 0.51;95%CI:0.48-0.54), TB by 51%(RR:0.49;95%CI:0.48-0.50), and child mortality by 70%(RR:0.30;95%CI:0.28 0.32). These effects diminished progressively as beneficiaries’ poverty levels decreased. Over the past two decades, BFP is estimated to have prevented 99,083 cases of AIDS, 235,489 of TB, and 200,627 child deaths. Conclusions. Conditional Cash Transfer programs can significantly alleviate the burden of AIDS, tuberculosis, and child mortality, with the most pronounced impacts observed among the poorest populations. Their effectiveness follows a gradient aligned with levels of individual vulnerability and can substantially reduce health inequities in low- and middle-income countries.

29 July 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
ELElisa Landin
Elisa Landin
Davide RasellaDavide Rasella
Davide Rasella
ABAudrey Claire Benson
Audrey Claire Benson
PKPeter D. Kirwan
Peter D. Kirwan
NSNatanael Silva
Natanael Silva
ASAndréa Ferreira Silva
Andréa Ferreira Silva
Background: Universal social protection (USP) is increasingly recognised as a key strategy for reducing poverty and health inequalities. Our study aims to evaluate the impact of expanding comprehensive social protection (SP) on under-5 mortality across low- and middle-income countries (LMICs) over the past two decades, and to forecast the effects of achieving USP compared with scenarios of SP deterioration. Methods: This retrospective impact evaluation integrated with forecasting analyses, used individual-level longitudinal data comprising 3.1 million child-years between 2000 and 2019 from 37 LMICs. We fitted two-way fixed-effects multivariable Poisson regression models with robust standard errors to estimate the effects of SP expansion on under-5 mortality, while assessing effect heterogeneity and performing extensive sensitivity and triangulation analyses. We subsequently integrated the retrospective data and effect estimates into validated dynamic microsimulation models based on 4.6 million child-years to forecast outcomes through 2035. Findings: A 10-percentage-point increase in SP coverage was associated with a 2·2% reduction in under-5 mortality (IRR:0·80;95%CI:0·70–0·92) between 2000 and 2019. The associations were stronger among children aged 1–4 years (IRR:0·54;95%CI:0·38–0·78), in rural populations (IRR:0·78;95%CI:0·67–0·90), and in low-income countries (IRR:0·67;95%CI:0·58–0·78). We estimated that observed SP expansion over the two-decade study period could have averted 3·34 million child deaths (95%CI:1·22–5·46). Forecasting analyses projected that achieving USP by 2035 could avert 2.46 million child deaths (95%UI:0·92–3·83) across the LMICs under study. Conversely, declines in SP coverage could lead to 1.00 million additional avoidable child deaths (95%UI:0·35–1·59). Interpretation: Achieving USP, as envisaged by target 1.3 of the 2030 Agenda for Sustainable Development, could substantially reduce child mortality in LMICs. Conversely, reduction in existing SP coverage due to declining development assistance and increasing fiscal austerity could result in substantial numbers of avoidable child deaths.